(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CULLINAN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CULLINAN

ST13

US500000097778211

Class

5, 42

Filing

97778211

Registration

7797946

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

01/23/2026

Trademark type

Word

Nice classes

5, 42

Filing date

02/02/2023

Registration date

05/20/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/20/2025

Last transaction

01/23/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2019-10-00

First use in commerce

2019-10-00

Drawing code

4

Owner type

03

Owner location

CAMBRIDGE, MA

Examiner

HAYNES, SAMANTHA M

Law office

N70

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

CULLINAN THERAPEUTICS, INC.
Cullinan Oncology, Inc.

Representatives

Malaika D. Tyson Lathrop GPM LLP

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical products for the prevention and treatment of cancer; therapeutic pharmaceuticals for the treatment of cancer; anti-cancer preparations being anti-cancer medicines comprised of small molecules and biologics; pharmaceuticals and therapeutic pharmaceuticals for the treatment of cancer and for use in the fields of oncology and immunology

Class 42

Pharmaceutical research and development; scientific research and development; medical research and development; medical research and development services in the fields of drug discovery and oncology

Publications

History of USPTO decisions and trademark events.

38 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/10/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/10/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/10/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/20/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

05/20/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/01/2025

PUBO

PUBLISHED FOR OPPOSITION

04/01/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/26/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/10/2025

IUAA

USE AMENDMENT ACCEPTED

03/10/2025

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

03/06/2025

IUAF

USE AMENDMENT FILED

03/06/2025

EAAU

TEAS AMENDMENT OF USE RECEIVED

03/06/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/06/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/06/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/06/2025

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

12/12/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

12/12/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/25/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/20/2024

GNRT

NON-FINAL ACTION E-MAILED

09/20/2024

CNRT

NON-FINAL ACTION WRITTEN

09/20/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/05/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/05/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

09/05/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

06/05/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

06/05/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

03/07/2024

GNFR

FINAL REFUSAL E-MAILED

03/07/2024

CNFR

FINAL REFUSAL WRITTEN

03/07/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/08/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/07/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/07/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/07/2023

GNRT

NON-FINAL ACTION E-MAILED

11/07/2023

CNRT

NON-FINAL ACTION WRITTEN

11/07/2023

DOCK

ASSIGNED TO EXAMINER

10/31/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/21/2023

Continuous trademark protection

Get notified about every new filing that threatens CULLINAN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.